Participate in the awards now

ViE Asia Awards is the time for the industry to come together and recognise their peers who have set themselves apart and have exhibited outstanding performance. With 7 distinguished categories, there is an opportunity for all types of organisations to get involved. Take this opportunity to nominate and vote for the most deserving organisations and individual!

Sponsor at the awards ›

Award categories

With 7 distinguished categories, there is an opportunity for all types of organisations to get involved. Take this opportunity to nominate and vote for the most deserving organisations and individuals today.

Leverage on the award to create brand awareness and thought leadership. Sponsor now!

Create your free online surveys with SurveyMonkey, the world's leading questionnaire tool.

Attend ›

the awards

Developing effective production strategies for multi-vaccine manufacturing in Asia

Evaluating specific challenges associated with manufacturing different vaccines
Developing robust approaches to fully utilise production facility
Exploring the different strategies available for ensuring quality control and regulatory compliance

Growing vaccine pipeline value through effective partnering and investment strategies in Asia

Asia contains a wide variety of vaccine markets, each with different advantages due to cultural, economic and geographic differences. Identifying the right partners to develop vaccines from initial R&D through trials to commercialization requires a strategic and well defined approach.
This workshop will assist participants in understanding how to approach the Asian market for external research and development and how to successfully build a pipeline through strategic partnerships.

Transitioning existing biologics processes into single use technology platform to enable global deployment

Factors to consider before implementation: performance equivalency, quality, logistics and business needs
Evaluating which single-use equipment to utilize, considering cost and which stage should be implemented first
Examining before and after implementation for optimum efficiency

Optimising cost-effective Japanese Encephalitis (JE) vaccine development in Asia

Evaluating current development on inactivated and live molecular JE vaccine for the global population
Tapping on lessons learnt from producing the vaccine in Asia
Case study: Assessing the long term immunity of live attenuated Japanese encephalitis chimeric virus vaccine

Innovative vaccine design: Important chemistry, manufacturing and controls (CMC) issues in adjuvant development

Uncovering new concepts and knowledge about innovative vaccine design; innate immunity and beyond
Tapping on advanced technologies of immune-manipulation and delivery system in Japan
Overcoming regulatory hurdles and harnessing the potential for adjuvants in Japan; key factors for very safe and efficacious vaccines

Innovative International Vaccine Developments

Leading global and Asian biotechs, pharmas and research institutes will showcase their latest vaccine developments looking for potential partners globally and across Asia. Potential partnerships run from research and development to licensing and collaboration in vaccine commercialization.

sponsor World Vaccine Congress Asia 2012 ›

Asia'a largest vaccine event